In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

Two research articles published in Nature Genetics shed new light on the cellular complexity of glioblastoma, the most aggressive type of brain cancer. An international team of scientists, including ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Saved from precursor B-cell acute lymphoblastic leukemia, the Nobel Prize winning CAR T-cell therapy gave Bryn Ailinger a ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Almost all stomach cancers are adenocarcinomas. But some rarer types may be more aggressive, affecting your treatment options and outlook. Stomach cancer (or gastric cancer) happens when cancerous ...